Essilorluxottica (ESLOY)
113.37
+1.48
(+1.32%)
USD |
OTCM |
May 17, 16:00
Essilorluxottica Price to Book Value: 2.425 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.425 |
| May 16, 2024 | 2.394 |
| May 15, 2024 | 2.420 |
| May 14, 2024 | 2.384 |
| May 13, 2024 | 2.369 |
| May 10, 2024 | 2.369 |
| May 09, 2024 | 2.374 |
| May 08, 2024 | 2.352 |
| May 07, 2024 | 2.367 |
| May 06, 2024 | 2.295 |
| May 03, 2024 | 2.295 |
| May 02, 2024 | 2.331 |
| May 01, 2024 | 2.322 |
| April 30, 2024 | 2.287 |
| April 29, 2024 | 2.307 |
| April 26, 2024 | 2.323 |
| April 25, 2024 | 2.320 |
| April 24, 2024 | 2.347 |
| April 23, 2024 | 2.348 |
| April 22, 2024 | 2.323 |
| April 19, 2024 | 2.324 |
| April 18, 2024 | 2.328 |
| April 17, 2024 | 2.289 |
| April 16, 2024 | 2.314 |
| April 15, 2024 | 2.296 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.297 |
| April 11, 2024 | 2.344 |
| April 10, 2024 | 2.315 |
| April 09, 2024 | 2.368 |
| April 08, 2024 | 2.395 |
| April 05, 2024 | 2.361 |
| April 04, 2024 | 2.359 |
| April 03, 2024 | 2.432 |
| April 02, 2024 | 2.407 |
| April 01, 2024 | 2.428 |
| March 28, 2024 | 2.425 |
| March 27, 2024 | 2.446 |
| March 26, 2024 | 2.422 |
| March 25, 2024 | 2.431 |
| March 22, 2024 | 2.416 |
| March 21, 2024 | 2.441 |
| March 20, 2024 | 2.464 |
| March 19, 2024 | 2.424 |
| March 18, 2024 | 2.407 |
| March 15, 2024 | 2.444 |
| March 14, 2024 | 2.417 |
| March 13, 2024 | 2.414 |
| March 12, 2024 | 2.403 |
| March 11, 2024 | 2.399 |
| March 08, 2024 | 2.390 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.127
Minimum
Apr 01 2020
2.464
Maximum
Mar 20 2024
1.864
Average
1.865
Median
Apr 27 2021
Price to Book Value Benchmarks
| DBV Technologies SA | 1.005 |
| Cellectis SA | 2.540 |
| PHAXIAM Therapeutics SA (DELISTED) | 0.4731 |
| Genfit SA | 2.495 |
| Innate Pharma SA | 3.818 |
Price to Book Value Related Metrics
| PE Ratio | 41.14 |
| PS Ratio | 3.714 |
| PEG Ratio | 0.9415 |
| Price to Free Cash Flow | 28.35 |
| Price | 113.37 |
| Earnings Yield | 2.43% |
| Market Cap | 102.51B |
| PEGY Ratio | 0.8736 |
| Operating PE Ratio | 29.64 |
| Normalized PE Ratio | 41.14 |